Sept. 17-23, 2019 Dispensary Compliance Updates

by Jayson Filingeri,


In California, A.B. 37 is headed to Gov. Gavin Newsom’s desk after the Senate passed the Bill on Sept. 4th. If the Bill is approved, cannabis business owners would be able to deduct expenses on their state income tax returns.

The Bureau of Cannabis Control (BCC) and the Department of Consumer Affairs’ Cannabis Enforcement Unit (DOI-CEU) announced enforcement action against two unlicensed cannabis retailers in Southern California selling illegal vape cartridges. The value of cannabis seized from the two unlicensed operators totaled over $2.8 million.

In Oregon, Rules Advisory Committee meetings are ongoing this week with another session to be held on Tuesday morning focused on Administrative Rules related to Licensing and Compliance issues.

In Washington, state regulators will hold a listen and learn session about draft conceptual marijuana penalty rules on September 26th. Attendees are asked to come prepared to offer feedback and suggestions regarding the following proposed new rule sections.

On Thursday September 19th, the rescheduled Marijuana Traceability Project (MTP) Advisory Committee meeting recurs, still convening every month at WSLCB headquarters given recent activity. This is not a formal public meeting, but has tended to be open to the public.


Federal / Banking

The Republican chair of the Senate Banking Committee said on Thursday that his panel will hold a vote on legislation allowing banks to service state-legal marijuana businesses this year. Chairman Mike Crapo (R-ID) told Politico that while he doesn’t support ending federal cannabis prohibition, his committee will take up the industry’s banking issues where there’s a growing bipartisan call to resolve the problem. The head of the American Bankers Association (ABA) predicted last week that the House would vote on the legislation before October.

DionyMed achieved a litigation victory last week in its unfair competition lawsuit against Eaze Technologies, Inc. (“Eaze”) by defeating Eaze’s motion to dismiss the complaint. The complaint alleges that “to gain an unfair competitive advantage in the California cannabis delivery market, Eaze is directing, coordinating, and participating in a scheme to defraud credit card companies and financial institutions into processing cannabis transactions in violation of a host of criminal laws.” As a result, DionyMed will now have the opportunity to conduct discovery into Eaze’s alleged credit and debit card fraud and bring the matter to trial.


Get monthly regulatory compliance updates delivered to your inbox.